Slim Sheath 22F Holmium Laser Enucleation of the Prostate (HoLEP) vs 26 F Sheath HoLEP for BPH: RCT
1 other identifier
interventional
142
1 country
1
Brief Summary
Holmium laser enucleation of the prostate (HoLEP) is routinely performed with 24F, 26F, and 28F laser scopes. Proponents of larger caliber scopes suggest that the larger scope size allows for improved visualization, hemostasis, and operative efficiencies. Proponents of a smaller scope diameter suggest that by eliminating the need for pre-HoLEP urethral dilation to accommodate a larger scope. It has also been proposed that a smaller caliber scope is less traumatic to the urethra resulting in lower rates of bladder neck contracture and urethral stricture disease. Currently, to our knowledge, there are no level one evaluation examining scope size 22F versus 26F sheath in laser enucleation outcomes. The aim of our study is to determine if a smaller diameter scope is associated with improved laser enucleation time, post-operative recovery, rates of same-day discharge, or increasing intra-operative or postoperative complication rates
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 16, 2024
CompletedFirst Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 16, 2025
CompletedAugust 9, 2024
August 1, 2024
1 year
July 30, 2024
August 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of Operating Time
Operating time as measured during the procedure measured in minutes.
Intra-op
Secondary Outcomes (8)
Time to Catheter Removal
Within 6 hours of procedure completion
Length of Hospital Stay
Within 6 hours of procedure completion
Continence status
One year post-procedure
International Prostate Symptom Score
One year post-procedure
Quality of Life (QOL) as scored on the International Prostate Symptom Score (IPSS)
One year post-procedure
- +3 more secondary outcomes
Study Arms (2)
22F Sheath Size
ACTIVE COMPARATORComparator arm for procedures using 22F sheath size
26F Sheath Size
ACTIVE COMPARATORComparator arm for procedures using 26F sheath size
Interventions
Participants in this group will have the 22F sheath size used in their procedure.
Participants in this group will have the 26F sheath size used in their procedure.
Eligibility Criteria
You may qualify if:
- Males over 50 years of age at the time of enrollment
- Referred to urology for refractory LUTS secondary to BPH
- Failed medical (non-surgical) treatment
- Prostate size on preoperative TRUS of \> 80 ml
- IPSS \>15, QOL score ≥3 and Qmax \<15 ml/sec
- Written informed consent to participate in the study
- Ability to comply with the requirements of the study procedures
You may not qualify if:
- Previous surgical treatment for BPH
- History of prostate cancer
- Prostate size \< 80 mL
- History of urethral stenosis or its management
- Known or suspected neurogenic bladder
- Participants with active urinary tract infection until appropriately treated
- Participants with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, P7B 6V4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hazem Elmansy
Thunder Bay Regional Health Sciences Centre
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
August 9, 2024
Study Start
April 16, 2024
Primary Completion
April 16, 2025
Study Completion
April 16, 2025
Last Updated
August 9, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share